Press Releases

Recent & Archived News

June 10, 2019

Ranchland Managers Have a New Tool to Fight Invasive Annual Grass

Ranchland managers who have long worried about the quality of forage available for their livestock have a new tool to fight the invasive annual grasses medusahead and ventenata. Esplanade® 200...

Learn more
June 07, 2019

Stop Invasive Annual Grasses from Destroying Western Ecosystems

An invader has been moving across the Western United States, degrading wildlife habitat, putting protected and threatened species like the Sage Grouse and desert tortoise at risk, reducing...

Learn more
June 04, 2019

Bayer and Arvinas, Inc. to develop novel Proteolysis-Targeting Chimera candidates for humans and plants

Bayer today announced a collaboration with Arvinas, Inc. (Nasdaq: ARVN), a biopharmaceutical company based in New Haven, Connecticut. The new life science research partnership uniquely leverages...

Learn more
June 03, 2019

New data on Vitrakvi® (larotrectinib) in TRK fusion cancer patients with brain metastases or primary central nervous system (CNS) tumors

Bayer today announced results of a new analysis from clinical trials investigating Vitrakvi® (larotrectinib) in patients with TRK fusion cancer with primary central nervous system (CNS) tumors or...

Learn more
May 30, 2019

Win the battle against scab and other wheat diseases with an 8.2 oz/A rate of Prosaro

Cereal diseases like scab affect grain quality and yield and rob wheat growers of profitability year after year. But growers can fight back and win with Prosaro® fungicide. The timely application...

Learn more
May 29, 2019

Bayer and Foundation Medicine announce global collaboration to develop next-generation sequencing (NGS)-based companion diagnostics in oncology

Bayer AG and Foundation Medicine, Inc. today announced a global collaboration for the development and commercialization of NGS-based companion diagnostics. This agreement allows for collaboration...

Learn more
May 29, 2019

Bayer Receives U.S. FDA Breakthrough Therapy Designation for Aliqopa™ (copanlisib) for the Treatment of Marginal Zone Lymphoma

Bayer announced today that the U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy Designation for Aliqopa™ (copanlisib) for the treatment of adult patients with relapsed...

Learn more
May 23, 2019

Shooting for the Stars: Bayer Launches Annual Alka-Rocket Challenge

Attention all university rocketeers who love rocket science and have dreams of being a GUINNESS WORLD RECORDS™ title holder: Bayer has an out-of-this-world challenge for you. For the third...

Learn more
May 23, 2019

Bayer Announces Five-Year Partnership with the World Federation of Hemophilia Humanitarian Aid Program

Today, Bayer announced a five-year partnership with the World Federation of Hemophilia (WFH) Humanitarian Aid Program, which will bring education, training, and Bayer's full portfolio of...

Learn more
May 21, 2019

Spring Warm Up Brings Increased Threats to Vineyard Profits

As temperatures warm up, so do mealybug populations and the potential for the devastating leafroll virus. Growers can preserve the health of their vines with a good understanding of how mealybug...

Learn more

 

Want even more Bayer news?

Check out our Social Media & Blogs.